Literature DB >> 19904588

Mitochondrial respiratory dysfunction and mutations in mitochondrial DNA in PINK1 familial parkinsonism.

Sergio Papa1, Anna Maria Sardanelli, Nazzareno Capitanio, Claudia Piccoli.   

Abstract

A summary is presented of the cellular function and topology of the protein products of genes whose mutations are associated with familial forms of parkinsonism, with particular emphasis on mitochondrial involvement. Observations are reviewed which show mitochondrial respiratory depression in the fibroblasts of a patient affected by familial parkinsonism associated with homozygous PINK1 mutation. The respiratory depression, which was due to loss of mitochondrial cytochrome c, was associated with decreased capacity of respiratory chain oxidative phosphorylation and enhanced cellular level of ROS. Sequence analysis of the overall mtDNA revealed coexistence with the PINK1 mutation of homoplasmic point mutations in the ND5 and ND6 genes of complex I. The presence of these mutations appears to have an impact on the development of the parkinsonism, which can also occur in the heterozygous PINK1 mutation state.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19904588     DOI: 10.1007/s10863-009-9252-4

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  76 in total

1.  The mitochondrial ND6 gene is a hot spot for mutations that cause Leber's hereditary optic neuropathy.

Authors:  P F Chinnery; D T Brown; R M Andrews; R Singh-Kler; P Riordan-Eva; J Lindley; D A Applegarth; D M Turnbull; N Howell
Journal:  Brain       Date:  2001-01       Impact factor: 13.501

2.  Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction.

Authors:  David D Arrington; Terry R Van Vleet; Rick G Schnellmann
Journal:  Am J Physiol Cell Physiol       Date:  2006-06-21       Impact factor: 4.249

3.  Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.

Authors:  Hans-Hermann Hoepken; Suzana Gispert; Blas Morales; Oliver Wingerter; Domenico Del Turco; Alexander Mülsch; Robert L Nussbaum; Klaus Müller; Stefan Dröse; Ulrich Brandt; Thomas Deller; Brunhilde Wirth; Alexei P Kudin; Wolfram S Kunz; Georg Auburger
Journal:  Neurobiol Dis       Date:  2006-11-30       Impact factor: 5.996

4.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

Review 5.  Mitochondrial free radical generation, oxidative stress, and aging.

Authors:  E Cadenas; K J Davies
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

6.  PINK1 controls mitochondrial localization of Parkin through direct phosphorylation.

Authors:  Yongsung Kim; Jeehye Park; Sunhong Kim; Saera Song; Seok-Kyu Kwon; Sang-Hee Lee; Tohru Kitada; Jin-Man Kim; Jongkyeong Chung
Journal:  Biochem Biophys Res Commun       Date:  2008-10-26       Impact factor: 3.575

7.  Leber hereditary optic neuropathy mutations in the ND6 subunit of mitochondrial complex I affect ubiquinone reduction kinetics in a bacterial model of the enzyme.

Authors:  Jukka Pätsi; Marko Kervinen; Moshe Finel; Ilmo E Hassinen
Journal:  Biochem J       Date:  2008-01-01       Impact factor: 3.857

8.  Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (Complex I).

Authors:  A Majander; M Finel; M Wikström
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

9.  Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.

Authors:  V Bonifati; C F Rohé; G J Breedveld; E Fabrizio; M De Mari; C Tassorelli; A Tavella; R Marconi; D J Nicholl; H F Chien; E Fincati; G Abbruzzese; P Marini; A De Gaetano; M W Horstink; J A Maat-Kievit; C Sampaio; A Antonini; F Stocchi; P Montagna; V Toni; M Guidi; A Dalla Libera; M Tinazzi; F De Pandis; G Fabbrini; S Goldwurm; A de Klein; E Barbosa; L Lopiano; E Martignoni; P Lamberti; N Vanacore; G Meco; B A Oostra
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

10.  Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia.

Authors:  Luigia Atorino; Laura Silvestri; Mirko Koppen; Laura Cassina; Andrea Ballabio; Roberto Marconi; Thomas Langer; Giorgio Casari
Journal:  J Cell Biol       Date:  2003-11-17       Impact factor: 10.539

View more
  8 in total

1.  Enzymatic dysfunction of mitochondrial complex I of the Candida albicans goa1 mutant is associated with increased reactive oxidants and cell death.

Authors:  Dongmei Li; Hui Chen; Abigail Florentino; Deepu Alex; Patricia Sikorski; William A Fonzi; Richard Calderone
Journal:  Eukaryot Cell       Date:  2011-03-11

Review 2.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

3.  Mitochondrial matters in Parkinson disease: introduction.

Authors:  George H Sack
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

4.  Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.

Authors:  Isidro Ferrer
Journal:  Parkinsons Dis       Date:  2011-02-17

5.  Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo.

Authors:  Phillip M Rappold; Mei Cui; Jonathan C Grima; Rebecca Z Fan; Karen L de Mesy-Bentley; Linan Chen; Xiaoxi Zhuang; William J Bowers; Kim Tieu
Journal:  Nat Commun       Date:  2014-11-05       Impact factor: 14.919

Review 6.  Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.

Authors:  Yixuan Liang; Li Cui; Jiguo Gao; Mingqin Zhu; Ying Zhang; Hong-Liang Zhang
Journal:  Mol Neurobiol       Date:  2021-04-06       Impact factor: 5.590

7.  The bioenergetic status relates to dopamine neuron loss in familial PD with PINK1 mutations.

Authors:  Rüediger Hilker; Ulrich Pilatus; Carsten Eggers; Johann Hagenah; Julia Roggendorf; Simon Baudrexel; Johannes C Klein; Bernd Neumaier; Gereon R Fink; Helmuth Steinmetz; Christine Klein; Elke Hattingen
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

Review 8.  In Vivo Mitochondrial Function in Idiopathic and Genetic Parkinson's Disease.

Authors:  Gabriele Dossi; Letizia Squarcina; Mario Rango
Journal:  Metabolites       Date:  2019-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.